Hims & Hers GLP-1 Review: The Subscription Telehealth Approach
Hims & Hers launched GLP-1 prescriptions in May 2024 at $199 per month and built $225 million in revenue from that business in a single calendar year — on a legal window that closed in October 2024 when the FDA removed semaglutide from its shortage list. The compounding business that powered that growth attracted two […]
Hims & Hers GLP-1 Review: The Subscription Telehealth Approach Read More »









